South Africa has taken a pivotal step towards pharmaceutical independence with the launch of a new South African cholera vaccine trial. The state-backed manufacturer, Biovac, in partnership with the South African Medical Research Council (SAMRC), has initiated clinical trials for a candidate oral cholera vaccine. Many hail this development as a crucial move to reduce Africa’s dependence on imported medicines.…